Fucoidan and cancer: A multifunctional molecule with anti-tumor potential

Marine Drugs

Volumn 13, Issue 4, 2015, Pages 2327-2346

  Atashrazm, Farzaneh ^a   Lowenthal, Ray M ^a   Woods, Gregory M ^a   Holloway, Adele F ^b   Dickinson, Joanne L ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Apoptosis; Cancer; Fucoidan; Synergy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; FUCOIDIN; LAPATINIB; PACLITAXEL; TAMOXIFEN; VEMURAFENIB; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; NEW DRUG; POLYSACCHARIDE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE; DIARRHEA; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MELANOMA; METASTASIS; MOLECULAR WEIGHT; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TOXICITY; TUMOR CELL; TUMOR XENOGRAFT; ANALYSIS; ANIMAL; BIOLOGICAL MODEL; BROWN ALGA; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECTS; FUNCTIONAL FOOD; METABOLISM; NEOPLASM METASTASIS; NEOPLASMS; PATHOLOGY; PRECLINICAL STUDY; SEAWEED;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; DRUG EVALUATION, PRECLINICAL; DRUGS, INVESTIGATIONAL; FUNCTIONAL FOOD; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; PHAEOPHYTA; POLYSACCHARIDES; SEAWEED;

EID: 84928596437     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13042327     Document Type: Review

References (80)

1. nd ed.; Sinauer Associates: Sunderland, MA, USA, 2000.
2. Joo, W.D.; Visintin, I.; Mor, G. Targeted cancer therapy - Are the days of systemic chemotherapy numbered? Maturitas 2013, 76, 308-314.
3. Cohen, P.R.; Bedikian, A.Y.; Kim, K.B. Appearance of new vemurafenib-associated melanocytic nevi on normal-appearing skin: Case series and a review of changing or new pigmented lesions in patients with metastatic malignant melanoma after initiating treatment with vemurafenib. J. Clin. Aesthet. Dermatol. 2013, 6, 27-37.
4. Huang, V.; Hepper, D.; Anadkat, M.; Cornelius, L. Cutaneous toxic effects associated with vemurafenib and inhibition of the braf pathway. Arch. Dermatol. 2012, 148, 628-633.
5. Dotan, E.; Aggarwal, C.; Smith, M.R. Impact of rituximab (rituxan) on the treatment of b-cell non-hodgkin's lymphoma. P T 2010, 35, 148-157.
6. Senderowicz, A.M. Flavopiridol: The first cyclin-dependent kinase inhibitor in human clinical trials. Investig. New Drugs 1999, 17, 313-320.
7. George, S.K.; Rajesh, R.; Kumar, S.S.; Sulekha, B.; Balaram, P. A polyherbal ayurvedic drug - Indukantha ghritha as an adjuvant to cancer chemotherapy via immunomodulation. Immunobiology 2008, 213, 641-649.
8. Caliceti, P.; Salmaso, S.; Bersani, S. Polysaccharide-based anticancer prodrugs. In Macromolecular Anticancer Therapeutics; Reddy, L.H., Couvreur, P., Eds.; Springer: New York, NY, USA, 2010; pp. 163-166.
9. Aravind, S.R.; Joseph, M.M.; Varghese, S.; Balaram, P.; Sreelekha, T.T. Antitumor and immunopotentiating activity of polysaccharide pst001 isolated from the seed kernel of tamarindus indica: An in vivo study in mice. Sci. World J. 2012, 2012, 361382.
10. Kalimuthu, S.; Kim, S. Fucoidan, a sulfated polysaccharides from brown algae as therapeutic target for cancer. In Handbook of Anticancer Drugs from Marine Origin; Kim, S., Ed.; Springer International Publishing: Cham, Switzerland, 2015; p. 147.
11. Mulloy, B.; Ribeiro, A.; Alves, A.; Vieira, R.; Mourao, P. Sulfated fucans from echinoderms have a regular tetrasaccharide repeating unit defined by specific patterns of sulfation at the o-2 and o-4 positions. J. Biol. Chem. 1994, 22113-22123.
12. Ribeiro, A.; Vieira, R.; Mourao, P.; Mulloy, B. A sulfated a-l-fucan from sea cucumber. Carbohydr. Res. 1994, 255, 225-240.
13. Kwak, J.Y. Fucoidan as a marine anticancer agent in preclinical development. Mar. Drugs 2014, 12, 851-870.
14. Zhang, Z.; Teruya, K.; Eto, H.; Shirahata, S. Fucoidan extract induces apoptosis in mcf-7 cells via a mechanism involving the ros-dependent jnk activation and mitochondria-mediated pathways. PLoS ONE 2011, 6, e27441.
15. Aisa, Y.; Miyakawa, Y.; Nakazato, T.; Shibata, H.; Saito, K.; Ikeda, Y.; Kizaki, M. Fucoidan induces apoptosis of human hs-sultan cells accompanied by activation of caspase-3 and down-regulation of erk pathways. Am. J. Hematol. 2005, 78, 7-14.
16. Riou, D.; Colliec-Jouault, S.; Pinczon du Sel, D.; Bosch, S.; Siavoshian, S.; Le Bert, V.; Tomasoni, C.; Sinquin, C.; Durand, P.; Roussakis, C. Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer Res. 1996, 16, 1213-1218.
17. Moreau, D.; Thomas-Guyon, H.; Jacquot, C.; Jugé, M.; Culioli, G.; Ortalo-Magné, A.; Piovetti, L.; Roussakis, C. An extract from the brown alga bifurcaria bifurcata induces irreversible arrest of cell proliferation in a non-small-cell bronchopulmonary carcinoma line. J. Appl. Phycol. 2006, 18, 87-93.
18. Boo, H.J.; Hong, J.Y.; Kim, S.C.; Kang, J.I.; Kim, M.K.; Kim, E.J.; Hyun, J.W.; Koh, Y.S.; Yoo, E.S.; Kwon, J.M.; et al. The anticancer effect of fucoidan in pc-3 prostate cancer cells. Mar. Drugs 2013, 11, 2982-2999.
19. Banafa, A.M.; Roshan, S.; Liu, Y.Y.; Chen, H.J.; Chen, M.J.; Yang, G.X.; He, G.Y. Fucoidan induces g1 phase arrest and apoptosis through caspases-dependent pathway and ros induction in human breast cancer mcf-7 cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2013, 33, 717-724.
20. Haneji, K.; Matsuda, T.; Tomita, M.; Kawakami, H.; Ohshiro, K.; Uchihara, J.; Masuda, M.; Takasu, N.; Tanaka, Y.; Ohta, T.; et al. Fucoidan extracted from cladosiphon okamuranus tokida induces apoptosis of human t-cell leukemia virus type 1-infected t-cell lines and primary adult t-cell leukemia cells. Nutr. Cancer 2005, 52, 189-201.
21. Fukahori, S.; Yano, H.; Akiba, J.; Ogasawara, S.; Momosaki, S.; Sanada, S.; Kuratomi, K.; Ishizaki, Y.; Moriya, F.; Yagi, M.; et al. Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro. Mol. Med. Rep. 2008, 1, 537-542.
22. Yamasaki-Miyamoto, Y.; Yamasaki, M.; Tachibana, H.; Yamada, K. Fucoidan induces apoptosis through activation of caspase-8 on human breast cancer mcf-7 cells. J. Agric. Food Chem. 2009, 57, 8677-8682.
23. Jin, J.O.; Song, M.G.; Kim, Y.N.; Park, J.I.; Kwak, J.Y. The mechanism of fucoidan-induced apoptosis in leukemic cells: Involvement of erk1/2, jnk, glutathione, and nitric oxide. Mol. Carcinog. 2010, 49, 771-782.
24. Kim, E.J.; Park, S.Y.; Lee, J.Y.; Park, J.H. Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol. 2010, 10, 96, doi:10.1186/1471-230X-10-96.
25. Boo, H.J.; Hyun, J.H.; Kim, S.C.; Kang, J.I.; Kim, M.K.; Kim, S.Y.; Cho, H.; Yoo, E.S.; Kang, H.K. Fucoidan from undaria pinnatifida induces apoptosis in a549 human lung carcinoma cells. Phytother. Res. 2011, 25, 1082-1086.
26. Costa, L.S.; Telles, C.B.; Oliveira, R.M.; Nobre, L.T.; Dantas-Santos, N.; Camara, R.B.; Costa, M.S.; Almeida-Lima, J.; Melo-Silveira, R.F.; Albuquerque, I.R.; et al. Heterofucan from sargassum filipendula induces apoptosis in hela cells. Mar. Drugs 2011, 9, 603-614.
27. Yang, L.; Wang, P.; Wang, H.; Li, Q.; Teng, H.; Liu, Z.; Yang, W.; Hou, L.; Zou, X. Fucoidan derived from undaria pinnatifida induces apoptosis in human hepatocellular carcinoma smmc-7721 cells via the ros-mediated mitochondrial pathway. Mar. Drugs 2013, 11, 1961-1976.
28. Cho, T.M.; Kim, W.J.; Moon, S.K. Akt signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells. Food Chem. Toxicol. 2014, 64, 344-352.
29. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
30. Ghobrial, I.M.; Witzig, T.E.; Adjei, A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005, 55, 178-194.
31. Zhang, Z.; Teruya, K.; Eto, H.; Shirahata, S. Induction of apoptosis by low-molecular-weight fucoidan through calcium- and caspase-dependent mitochondrial pathways in mda-mb-231 breast cancer cells. Biosci. Biotechnol. Biochem. 2013, 77, 235-242.
32. Koyanagi, S.; Tanigawa, N.; Nakagawa, H.; Soeda, S.; Shimeno, H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem. Pharmacol. 2003, 65, 173-179.
33. Xue, M.; Ge, Y.; Zhang, J.; Wang, Q.; Hou, L.; Liu, Y.; Sun, L.; Li, Q. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PLoS ONE 2012, 7, e43483.
34. Zhu, C.; Cao, R.; Zhang, S.X.; Man, Y.N.; Wu, X.Z. Fucoidan inhibits the growth of hepatocellular carcinoma independent of angiogenesis. Evid Based Complement. Alternat. Med. 2013, 2013, 692549.
35. Coombe, D.R.; Parish, C.R.; Ramshaw, I.A.; Snowden, J.M. Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int. J. Cancer 1987, 39, 82-88.
36. Soeda, S.; Ishida, S.; Shimeno, H.; Nagamatsu, A. Inhibitory effect of oversulfated fucoidan on invasion through reconstituted basement membrane by murine lewis lung carcinoma. Jpn. J. Cancer Res. 1994, 85, 1144-1150.
37. Liu, J.M.; Bignon, J.; Haroun-Bouhedja, F.; Bittoun, P.; Vassy, J.; Fermandjian, S.; Wdzieczak-Bakala, J.; Boisson-Vidal, C. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin. Anticancer Res. 2005, 25, 2129-2133.
38. Cumashi, A.; Ushakova, N.A.; Preobrazhenskaya, M.E.; D'Incecco, A.; Piccoli, A.; Totani, L.; Tinari, N.; Morozevich, G.E.; Berman, A.E.; Bilan, M.I.; et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17, 541-552.
39. Lee, H.; Kim, J.S.; Kim, E. Fucoidan from seaweed fucus vesiculosus inhibits migration and invasion of human lung cancer cell via pi3k-akt-mtor pathways. PLoS ONE 2012, 7, e50624.
40. Patel, M.K.; Mulloy, B.; Gallagher, K.L.; O'Brien, L.; Hughes, A.D. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells. Thromb. Haemost. 2002, 87, 149-154.
41. Hsu, H.Y.; Lin, T.Y.; Hwang, P.A.; Tseng, L.M.; Chen, R.H.; Tsao, S.M.; Hsu, J. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent tgfbeta receptor degradation in breast cancer. Carcinogenesis 2013, 34, 874-884.
42. Hyun, J.H.; Kim, S.C.; Kang, J.I.; Kim, M.K.; Boo, H.J.; Kwon, J.M.; Koh, Y.S.; Hyun, J.W.; Park, D.B.; Yoo, E.S.; et al. Apoptosis inducing activity of fucoidan in hct-15 colon carcinoma cells. Biol. Pharm. Bull. 2009, 32, 1760-1764.
43. Zhuang, S.; Schnellmann, R.G. A death-promoting role for extracellular signal-regulated kinase. J. Pharmacol. Exp. Ther. 2006, 319, 991-997.
44. Ale, M.T.; Maruyama, H.; Tamauchi, H.; Mikkelsen, J.D.; Meyer, A.S. Fucoidan from sargassum sp. And fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int. J. Biol. Macromol. 2011, 49, 331-336.
45. Azuma, K.; Ishihara, T.; Nakamoto, H.; Amaha, T.; Osaki, T.; Tsuka, T.; Imagawa, T.; Minami, S.; Takashima, O.; Ifuku, S.; et al. Effects of oral administration of fucoidan extracted from cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model. Mar. Drugs 2012, 10, 2337-2348.
46. Shimizu, J.; Wada-Funada, U.; Mano, H.; Matahira, Y.; Kawaguchi, M.; Wada, M. Proportion of murine cytotoxic t cells is increased by high molecular-weight fucoidan extracted from okinawa mozuku (cladosiphon okamuranus). J. Health Sci. 2005, 51, 394-397.
47. Hu, Y.; Cheng, S.C.; Chan, K.T.; Ke, Y.; Xue, B.; Sin, F.W.; Zeng, C.; Xie, Y. Fucoidin enhances dendritic cell-mediated t-cell cytotoxicity against ny-eso-1 expressing human cancer cells. Biochem. Biophys. Res. Commun. 2010, 392, 329-334.
48. Jin, J.O.; Zhang, W.; Du, J.Y.; Wong, K.W.; Oda, T.; Yu, Q. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific t cell immune responses. PLoS ONE 2014, 9, e99396.
49. Teas, J.; Harbison, M.L.; Gelman, R.S. Dietary seaweed (laminaria) and mammary carcinogenesis in rats. Cancer Res. 1984, 44, 2758-2761.
50. Wakefield, L.M.; Roberts, A.B. Tgf-beta signaling: Positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 2002, 12, 22-29.
51. Humphrey, P.A.; Wong, A.J.; Vogelstein, B.; Zalutsky, M.R.; Fuller, G.N.; Archer, G.E.; Friedman, H.S.; Kwatra, M.M.; Bigner, S.H.; Bigner, D.D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA 1990, 87, 4207-4211.
52. Lee, N.Y.; Ermakova, S.P.; Zvyagintseva, T.N.; Kang, K.W.; Dong, Z.; Choi, H.S. Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in jb6 cl41 cells. Food Chem. Toxicol. 2008, 46, 1793-1800.
53. Silchenko, A.S.; Kusaykin, M.I.; Kurilenko, V.V.; Zakharenko, A.M.; Isakov, V.V.; Zaporozhets, T.S.; Gazha, A.K.; Zvyagintseva, T.N. Hydrolysis of fucoidan by fucoidanase isolated from the marine bacterium, formosa algae. Mar. Drugs 2013, 11, 2413-2430.
54. Irhimeh, M.R.; Fitton, J.H.; Lowenthal, R.M.; Kongtawelert, P. A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find Exp. Clin. Pharmacol. 2005, 27, 705-710.
55. Tokita, Y.; Nakajima, K.; Mochida, H.; Iha, M.; Nagamine, T. Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwich elisa. Biosci. Biotechnol. Biochem. 2010, 74, 350-357.
56. Deux, J.F.; Meddahi-Pelle, A.; le Blanche, A.F.; Feldman, L.J.; Colliec-Jouault, S.; Bree, F.; Boudghene, F.; Michel, J.B.; Letourneur, D. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1604-1609.
57. Kimura, R.; Rokkaku, T.; Takeda, S.; Senba, M.; Mori, N. Cytotoxic effects of fucoidan nanoparticles against osteosarcoma. Mar. Drugs 2013, 11, 4267-4278.
58. Thelen, T.; Hao, Y.; Medeiros, A.I.; Curtis, J.L.; Serezani, C.H.; Kobzik, L.; Harris, L.H.; Aronoff, D.M. The class a scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for clostridium sordellii expressed by human decidual macrophages. J. Immunol. (Baltimore, Md. 1950) 2010, 185, 4328-4335.
59. Ding, Z.; Issekutz, T.B.; Downey, G.P.; Waddell, T.K. L-selectin stimulation enhances functional expression of surface cxcr4 in lymphocytes: Implications for cellular activation during adhesion and migration. Blood 2003, 101, 4245-4252.
60. Yamasaki, Y.; Yamasaki, M.; Tachibana, H.; Yamada, K. Important role of beta1-integrin in fucoidan-induced apoptosis via caspase-8 activation. Biosci. Biotechnol. Biochem. 2012, 76, 1163-1168.
61. Ikeguchi, M.; Yamamoto, M.; Arai, Y.; Maeta, Y.; Ashida, K.; Katano, K.; Miki, Y.; Kimura, T. Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer. Oncol. Lett. 2011, 2, 319-322.
62. Lv, Y.; Song, Q.; Shao, Q.; Gao, W.; Mao, H.; Lou, H.; Qu, X.; Li, X. Comparison of the effects of marchantin c and fucoidan on sflt-1 and angiogenesis in glioma microenvironment. J. Pharm. Pharmacol. 2012, 64, 604-609.
63. Vishchuk, O.S.; Ermakova, S.P.; Zvyagintseva, T.N. The effect of sulfated (1 - >3)-alpha-l-fucan from the brown alga saccharina cichorioides miyabe on resveratrol-induced apoptosis in colon carcinoma cells. Mar. Drugs 2013, 11, 194-212.
64. Zhang, Z.; Teruya, K.; Yoshida, T.; Eto, H.; Shirahata, S. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in mda-mb-231 and mcf-7 breast cancer cells. Mar. Drugs 2013, 11, 81-98.
65. Oh, B.; Kim, J. Anticancer effect of fucoidan in combination with tyrosine kinase inhibitor lapatinib. Evid. Based Complement. Alternat. Med. 2014, 2014, 865375.
66. Alekseyenko, T.V.; Zhanayeva, S.Y.; Venediktova, A.A.; Zvyagintseva, T.N.; Kuznetsova, T.A.; Besednova, N.N.; Korolenko, T.A. Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the okhotsk sea fucus evanescens brown alga. Bull. Exp. Biol. Med. 2007, 143, 730-732.
67. Mabeau, S.; Kloareg, B.; Joseleau, J. Fractionation and analysis of fucans from brown algae. Phytochemistry 1990, 29, 2441-2445.
68. Black, W. The seasonal variation in the combined l-fucose content of the common british laminariaceae and fucaceae. J. Sci. Food Agric. 1954, 5, 445-448.
69. Haroun-Bouhedja, F.; Ellouali, M.; Sinquin, C.; Boisson-Vidal, C. Relationship between sulfate groups and biological activities of fucans. Thromb. Res. 2000, 100, 453-459.
70. Cho, M.L.; Lee, B.Y.; You, S.G. Relationship between oversulfation and conformation of low and high molecular weight fucoidans and evaluation of their in vitro anticancer activity. Molecules 2010, 16, 291-297.
71. Yang, C.; Chung, D.; Shin, I.S.; Lee, H.; Kim, J.; Lee, Y.; You, S. Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of undaria pinnatifida. Int. J. Biol. Macromol. 2008, 43, 433-437.
72. Lee, J.; Kim, J.; Moon, C.; Kim, S.H.; Hyun, J.W.; Park, J.W.; Shin, T. Radioprotective effects of fucoidan in mice treated with total body irradiation. Phytother. Res. 2008, 22, 1677-1681.
73. Chung, H.J.; Jeun, J.; Houng, S.J.; Jun, H.J.; Kweon, D.K.; Lee, S.J. Toxicological evaluation of fucoidan from undaria pinnatifidain vitro and in vivo. Phytother. Res. 2010, 24, 1078-1083.
74. Li, N.; Zhang, Q.; Song, J. Toxicological evaluation of fucoidan extracted from laminaria japonica in wistar rats. Food Chem. Toxicol. 2005, 43, 421-426.
75. Cooper, R.; Dragar, C.; Elliot, K.; Fitton, J.H.; Godwin, J.; Thompson, K. Gfs, a preparation of tasmanian undaria pinnatifida is associated with healing and inhibition of reactivation of herpes. BMC Complement. Altern. Med. 2002, 2, 11; doi:10.1186/1472-6882-2-11.
76. Mori, N.; Nakasone, K.; Tomimori, K.; Ishikawa, C. Beneficial effects of fucoidan in patients with chronic hepatitis c virus infection. World J. Gastroenterol. 2012, 18, 2225-2230.
77. Irhimeh, M.R.; Fitton, J.H.; Lowenthal, R.M. Fucoidan ingestion increases the expression of cxcr4 on human cd34+ cells. Exp. Hematol. 2007, 35, 989-994.
78. Millet, J.; Jouault, S.C.; Mauray, S.; Theveniaux, J.; Sternberg, C.; Boisson Vidal, C.; Fischer, A.M. Antithrombotic and anticoagulant activities of a low molecular weight fucoidan by the subcutaneous route. Thromb. Haemost. 1999, 81, 391-395.
79. Araya, N.; Takahashi, K.; Sato, T.; Nakamura, T.; Sawa, C.; Hasegawa, D.; Ando, H.; Aratani, S.; Yagishita, N.; Fujii, R.; et al. Fucoidan therapy decreases the proviral load in patients with human t-lymphotropic virus type-1-associated neurological disease. Antivir. Ther. 2011, 16, 89-98.
80. Myers, S.P.; O'Connor, J.; Fitton, J.H.; Brooks, L.; Rolfe, M.; Connellan, P.; Wohlmuth, H.; Cheras, P.A.; Morris, C. A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis. Biologics 2010, 4, 33-44.